Metabolic and Immunological Phenotyping in Patients With Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-07

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An observational study to investigate cachexia in participants with non-haematological cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

NCT06073431

Advanced Colorectal Carcinoma Advanced Lung Non-Small Cell Carcinoma Advanced Pancreatic Adenocarcinoma +6 more

RECRUITING

Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC

NCT06808113

Non Small Cell Lung Cancer

ACTIVE_NOT_RECRUITING

Assessment of the Prevalence of Sarcopenia by CT Scan in Patients Diagnosed With Head & Neck Cancer

NCT04804852

Sarcopenia Cancer of Head and Neck CT Scan

UNKNOWN

Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.

NCT02968979

Non-small Cell Lung Cancer Cachexia

COMPLETED

The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer

NCT04594863

Cachexia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A single-centre, non-randomised, observational study. This study will investigate the systemic metabolic and immunological changes that occur in cachexia. The aim is to better understand the mechanism(s) underlying weight loss in people with non-haematological cancer. This will help to facilitate future research to generate treatments to reverse weight loss and improve outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Non-Hematologic Malignancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

* Have given written informed consent to participate
* Be aged 18 years or over at the time of signing the informed consent form
* Have a histological or cytological diagnosis of a non-haematological cancer
* Are willing and able to comply with study procedures and visits

Exclusion Criteria

* Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics
* Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase)
* Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study.
* Intolerance to dairy products
* Women, who are pregnant, plan to become pregnant or are lactating

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes